Skip to main content
Pharmatica — home Pharmatica
  • Insights
  • Topics
    • Therapeutic Drug Discovery
    • Clinical Development
    • Technical Operations
    • HealthTech & AI
  • Interviews
  • Council
  • Services
    • Sentinel
    • Vanguard

HealthTech & AI

Discover how artificial intelligence and healthtech are transforming healthcare and drug development.

  • Insights
  • Interviews
  • AI & Machine Learning
  • AI and Automation
  • AI Drug Development
  • AI Drug Discovery
  • AI in Clinical Trials
  • AI Pharma
  • ALCOA
  • Artificial Intelligence in Healthcare
  • Biomedical R&D
  • Biotech
  • Cell and Gene Therapy
  • Clinical Data
  • Clinical Logistics
  • Clinical Outcomes
  • Clinical Trial Design
  • Clinical Trial Regulation
  • CMC
  • Continuous Manufacturing
  • Data and Digital Health
  • Data Integrity
  • Decentralised Manufacturing
  • Diagnostics
  • Digital Health
  • Drug Delivery
  • Drug Discovery
  • Drug Production
  • Healthcare Technology
  • HTA and Reimbursement
  • Immunology and Immunotherapy
  • Infectious Diseases and Vaccines
  • Investment and Market Analysis
  • LLMs in Pharma
  • Longevity
  • Machine Learning in Pharma
  • Medical Devices
  • Medical Imaging
  • Medtech
  • Multiomics
  • Neurological Disease
  • Next-gen Modalities
  • Oncology
  • Orphan Drugs
  • Patient Enrolment
  • Pharma Intelligence
  • Pharma Policy
  • Pharma Regulation
  • Pharma Supply Chains
  • Pharmaceutical Compliance
  • Pharmaceutical R&D
  • Precision Medicine
  • Preclinical Development
  • Pricing and Market Access
  • Quality
  • Rare Diseases
  • Tech and Innovation
  • Translational Science and Biomarkers
  • Wearables

Filters

Type at least 2 characters to search

Showing results for
  • Content
  • Experts
  • Industry partners
Read Optimising Preclinical Pharmacology for Oncology NMEs
Profile photo of Nicole Dale
Nicole Dale

Optimising Preclinical Pharmacology for Oncology NMEs

Oncology researcher performing preclinical pharmacology testing for new molecular entities (NMEs), illustrating oncology drug development, translational research, biomarker discovery, and advanced preclinical model optimisation.

Over 90% of oncology NMEs that succeed in animal studies fail in clinical trials. This analysis examines how to optimise preclinical pharmacology models to improve translational success.

Preclinical Development
Read Success for Non-Animal Testing of Preclinical Toxicity?
Profile photo of Nicole Dale
Nicole Dale

Success for Non-Animal Testing of Preclinical Toxicity?

Pharmatica hyper-realistic image of a human organ-on-chip platform with cultured cells used for non-animal testing in drug discovery in order to determine preclinical toxicity in a pharmaceutical research laboratory.

Can non-animal testing methods be used in preclinical drug discovery? Here is what the evidence is for their accuracy and limits assessing preclinical toxicity.

Preclinical Development
Read Strategic Pharma Intelligence Drives Better Decisions in Life Sciences
Profile photo of Nicole Dale
Nicole Dale

Strategic Pharma Intelligence Drives Better Decisions in Life Sciences

Strategic pharma intelligence concept featuring Pharmatica branding, molecular structures, global business leaders in discussion, and pharmaceutical innovation imagery, representing data-driven decision-making, industry analysis, and executive strategy in the life sciences sector.

Find out why strategic pharma intelligence is needed to connect insights and to guide confident decision-making across the drug development lifecycle.

Pharma Intelligence
Read Why the U.S. Medicine Supply Chain Is One Shortage Away from Crisis
Profile photo of Nicole Dale
Nicole Dale

Why the U.S. Medicine Supply Chain Is One Shortage Away from Crisis

Graphic featuring a dark teal world map with glowing teal network nodes connected by dotted lines across various continents. The bottom portion shows white pills moving along a factory conveyor belt, with a translucent molecular structure on the left and the white "Pharmatica" logo in the bottom right corner.

The USP's 2025 Vulnerable Medicines List flags 100 drugs at high risk. Here is what to do to build pharma supply chain resilience.

Pharma Supply Chains
Read Seven Ways AI Is Solving Pharmaceutical Supply Chain Problems
Profile photo of Nicole Dale
Nicole Dale

Seven Ways AI Is Solving Pharmaceutical Supply Chain Problems

A scientist in a white lab coat and blue tie holds a digital stylus, interacting with a glowing teal infographic flow. This depicts AI in pharmaceutical supply chains using three glowing icons connected by arrows: a molecular structure with a downward arrow, a chemical processing/bioreactor tank, and a hospital or clinic building labeled "CLINIC" with a medical cross. A dark blue band stretches across the upper portion of the image, featuring the white "Pharmatica" infinity-loop logo and bran

AI is tackling the pharmaceutical supply chain's most persistent problems, from demand forecasting to counterfeit detection. See the top 7 ways AI is improving supply chain resiliency.

Pharma Supply Chains
Read The Looming Threat of Geopolitical Risk in Clinical Supply Chains
Profile photo of Nicole Dale
Nicole Dale

The Looming Threat of Geopolitical Risk in Clinical Supply Chains

A digital globe surrounded by a glowing cyan network mesh, overlaid on a dark green background with DNA strands, molecular structures, and the Pharmatica logo.

Geopolitical risk is reshaping how clinical supply chains are managed, demanding resilience and foresight. Learn why building supply chain resilience is the key for clinical trial success.

Pharma Supply Chains
  • Load more
  • Adaptive Clinical Trials
  • Advanced Therapies
  • ageing clocks
  • AI & Advanced Healthcare
  • AI & Machine Learning
  • AI and Automation
  • AI Drug Development
  • AI Drug Discovery
  • AI in Clinical Trials
  • AI Pharma
  • ALCOA
  • Artificial Intelligence in Healthcare
  • biological age
  • Biological Ageing
  • Biologics
  • biomarkers
  • Biomedical R&D
  • Bioprocessing
  • Biostatistics
  • Biotech
  • Cardiometabolic Diseases
  • Cell and Gene Therapy
  • Clinical Data
  • Clinical Logistics
  • Clinical Outcomes
  • Clinical Trial Design
  • Clinical Trial Regulation
  • Clinical Trial Strategy
  • clinical trials
  • CMC
  • Cold Chain
  • Commercial Strategy
  • Commercialisation & Medical Affairs
  • Continuous Manufacturing
  • Contract Manufacturing (CDMO/CMO)
  • Data and Digital Health
  • Data Integrity
  • Data Protection
  • Decentralised Clinical Trials
  • Decentralised Manufacturing
  • Deep Longevity
  • Diagnostics
  • Digital Ecosystems
  • Digital Health
  • Drug Delivery
  • Drug Design & Delivery
  • Drug Discovery
  • Drug Production
  • Electronic Data Capture
  • Enterprise Validation
  • GDPR
  • Generics
  • Genetics & Molecular Biology
  • Global Regulatory Affairs
  • Healthcare Technology
  • HTA and Reimbursement
  • HTS and Automation
  • Immunology and Immunotherapy
  • Infectious Diseases and Vaccines
  • Investment and Market Analysis
  • Labelling and Packaging
  • LLMs in Pharma
  • Longevity
  • M&A & Operations
  • Machine Learning in Pharma
  • Market Access & Reimbursement
  • Medical Devices
  • Medical Governance
  • Medical Imaging
  • Medtech
  • Multiomics
  • Neurological Disease
  • Next-gen Modalities
  • Ocular Diseases
  • Oncology
  • Oncology & Radiotherapeutics
  • Orphan Drugs
  • Patient Centricity and Outcomes
  • Patient Enrolment
  • patient stratification
  • Peptides and Obesity Treatments
  • Pharma Intelligence
  • Pharma Policy
  • pharma R&D
  • Pharma Regulation
  • Pharma Supply Chains
  • Pharmaceutical Compliance
  • pharmaceutical industry
  • Pharmaceutical R&D
  • Pharmacology
  • Pharmacovigilance
  • Pharmacovigilance & Safety
  • Pharmatica
  • Post-market
  • Precision Medicine
  • Preclinical Development
  • Pricing and Market Access
  • Quality
  • Quality Assurance & cGMP
  • Rare Diseases
  • Regulatory & IP
  • Remote Clinical Monitoring
  • Remote Monitoring
  • Research Informatics
  • RWE Strategy
  • Safety & Toxicology
  • Small Molecules
  • Specialised Indications
  • Sterile Manufacturing
  • Strategic Sourcing & Procurement
  • Supply Network Strategy
  • Tech and Innovation
  • Telemedicine
  • The Discovery Loop
  • Translational & Pre-clinical Research
  • Translational & Surgical Biology
  • Translational Science and Biomarkers
  • Trial Operations & CMC
  • Wearables

No result found for

Pharmatica — home

Get Started

LinkedIn logo Sign in with LinkedIn Google logo Sign in with Google
or
  • Access trusted pharma insights for free
  • Discover actionable analysis from industry experts
  • Network with pharma professionals across R&D, clinical and regulatory
  • Unlock exclusive analyst-led interviews and reports
  • Share your perspective with our global pharma community
Coming Soon…
  • Access expert pharma resources for your team
  • Network with professionals and industry leaders
  • Gain exclusive insights from a global pharma community
Forgot your password?
LinkedIn logo Sign up with LinkedIn Google logo Sign up with Google
Already have an account?
  • Privacy Policy
  • Contact us
Pharmatica — home Pharmatica

Evidence-led pharmaceutical analysis covering drug discovery, clinical development, regulatory policy and industry innovation, designed for professionals shaping the future of life sciences.

  • Pharmatica on LinkedIn
  • Pharmatica on YouTube

Topics

  • Therapeutic Drug Discovery
  • Clinical Development
  • Technical Operations
  • HealthTech & AI

Resources

  • Insights
  • Interviews

Network

  • Scientific Council

Company

  • About
  • Sentinel
  • Vanguard
  • FAQ

Subscribe to our newsletter

  • Contact us
  • Privacy policy
  • Editorial policy
  • GDPR policy
  • Sitemap

All rights reserved. © 2026 | Pharmatica